Table 3.
Primary causes of death in the study cohort.
| Dec | mBuCy | |
|---|---|---|
| No. of patients | 10 | 21 |
| Relapse (n, %) | 8 (80.0%) | 16 (76.2%) |
| TRM (n, %) | ||
| aGVHD | 0 | 0 |
| cGVHD | 0 | 2 (9.5%) |
| Rejection | 1 (10.0%) | 0 |
| Infection | 1 (10.0%) | 2 (9.5%) |
| Other | 0 | 1 (4.8%) |
Dec, decitabine; mBuCy, modified busulfan/cyclophosphamide; TRM, treatment-related mortality; aGVHD, acute graft-versus-host disease; cGVHD, chronic graft versus host disease.